Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polmacoxib Phase II in Osteoarthritis
NCT00530452Phase 2Unknown
- Sponsor
- Crystal Genomics
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of polmacoxib in osteoarthritis (OA), sponsored by Crystal Genomics. Status: unknown.
02
Drugs
polmacoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00530452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530452.